Cargando…
Current and Future Therapeutical Options in Alport Syndrome
Alport syndrome (AS) is a hereditary kidney disease caused by pathogenic variants in COL4A3 and COL4A4 genes with autosomal recessive or autosomal dominant transmission or in the COL4A5 gene with X-linked inheritance. Digenic inheritance was also described. Clinically it is associated with microscop...
Autores principales: | Reiterová, Jana, Tesař, Vladimír |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056269/ https://www.ncbi.nlm.nih.gov/pubmed/36982595 http://dx.doi.org/10.3390/ijms24065522 |
Ejemplares similares
-
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
por: Reiterová, Jana, et al.
Publicado: (2022) -
Multidisciplinary Management of Alport Syndrome: Current Perspectives
por: Kashtan, Clifford
Publicado: (2021) -
Alport Syndrome: Clinical Spectrum and Therapeutic Advances
por: Gregorio, Vanessa De, et al.
Publicado: (2023) -
Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011) -
Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)